Key result
Individuals carrying the CC genotype of the ANGPT2 rs2442598 polymorphism were 3.29-fold more likely to develop systemic sclerosis compared with those carrying the CT variant (OR 3.288).
Why the study?
Angiopoietin-1 and -2 concentrations are associated with systemic sclerosis, but whether ANGPT1 and ANGPT2 single nucleotide polymorphisms predict disease susceptibility in Polish Caucasian patients remained unexplored.
Are ANGPT1 and ANGPT2 polymorphisms associated with systemic sclerosis susceptibility and phenotype in Polish Caucasian patients?
Case-Control (n=86)
No
Are ANGPT1 and ANGPT2 polymorphisms associated with systemic sclerosis susceptibility and phenotype in Polish Caucasian patients?
The ANGPT2 rs2442598 polymorphism may represent a susceptibility locus for systemic sclerosis, while ANGPT2 rs3739390 and ANGPT1 rs2507800 variants may affect the disease profile.
No immediate change to SSc care; hypothesis-generating for ANGPT SNPs as susceptibility markers.
INTRODUCTION: Angiopoietin-1 (Ang-1) and -2 (Ang-2) concentrations were found to be associated with systemic sclerosis (SSc). OBJECTIVES: We explored whether single nucleotide polymorphisms of Ang-1 (ANGPT1) and Ang-2 (ANGPT2) genes can predict SSc susceptibility in Polish Caucasian patients. PATIENTS AND METHODS: Genotyping by reverse transcriptase–polymerase chain reaction and Sanger sequencing was performed in 48 patients with SSc and 38 controls. RESULTS: Individuals with the CC genotype of ANGPT2 rs2442598 were 3.29-fold more likely to develop SSc (odds ratio [OR], 3.288; 95% CI, 1.212–8.915; P = 0.02) compared with those carrying the CT variant. Subgroup analysis revealed that the G allele, CG, and CG+GG genotypes of ANGPT2 rs3739390 were associated with a 9-fold higher risk to develop a diffuse form of the disease compared with the C allele or CC genotype (OR, 9.00; 95% CI, 2.102–38.519; P = 0.002 and OR, 9.00; 95% CI, 1.112–72.824; P = 0.03, respectively) and patients carrying the CG variant presented with higher serum Ang-2 levels than those carrying the CC variant (P = 0.001). On the contrary, the likelihood of a diffuse disease subtype was 8.77-fold lower for the TT+AT than for the AA genotype of ANGPT1 rs2507800 (OR, 0.114; 95% CI, 0.014–0.932; P= 0.04). The C allele of ANGPT2 rs3739390 was associated with a 4.83-fold lower risk of digital ulcers (OR, 4.833; 95% CI, 1.089–21.437; P= 0.03). CONCLUSIONS: We concluded for the first time in the literature that the ANGPT2 rs2442598 polymorphism might represent a susceptibility locus for SSc, whereas the ANGPT2 rs3739390 and ANGPT1 rs2507800 variants may affect the disease profile.
No takes yet. Share an insight, caveat, or question.
Michalska‐Jakubus et al. (2021) conducted a case-control in Systemic sclerosis (n=86). ANGPT2 rs2442598 CC genotype vs. ANGPT2 rs2442598 CT genotype was evaluated on Susceptibility to systemic sclerosis (OR 3.288, 95% CI 1.212-8.915, p=0.02). Individuals carrying the CC genotype of the ANGPT2 rs2442598 polymorphism were 3.29-fold more likely to develop systemic sclerosis compared with those carrying the CT variant (OR 3.288).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: